Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study

Indian Journal of Critical Care Medicine

Volumn 18, Issue 12, 2014, Pages 822-824

  Basu, Reshma ^a   Pathak, Sunjay ^a   Goyal, Jyoti ^a   Chaudhry, Rajeev ^a   Goel, Rati B ^a   Barwal, Anil ^a  

^a ARTEMIS HOSPITAL   (India)

Author keywords

CytoSorb; hemoadsorption; septic shock; systemic inflammatory response syndrome

Indexed keywords

CYTOKINE; HYDROCORTISONE; HYPERTENSIVE FACTOR; MEROPENEM;

ADJUVANT THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BLOOD FILTER; CASE REPORT; CORTICOSTEROID THERAPY; DYSPNEA; FATIGUE; FEMALE; HEMADSORPTION; HEMOPERFUSION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; INOTROPISM; KIDNEY INJURY; MALAISE; MEDICAL HISTORY; MEDICAL TECHNOLOGY; MORBID OBESITY; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DYSFUNCTION SCORE; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SLEEP DISORDERED BREATHING; UROSEPSIS;

EID: 84919625612     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.146321     Document Type: Article

References (13)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, CUB-Réa Network. Current epidemiology of septic shock: The CUB-Réa network. Am J Respir Crit Care Med 2003;168:165-72.
2. Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, et al. A novel adsorbent of circulating bacterial toxins and cytokines: The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit Care Med 2006;34:800-6.
3. Schädler D, Porzelius C, Jörres A, Marx G, Meier-Hellmann A, Putensen C, et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients. Crit Care 2013;17:62.
4. Taniguchi T, Kurita A, Mukawa C, Yamamoto K, Inaba H. Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia. Intensive Care Med 2007;33:529-33.
5. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008;36:1573-7.
6. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, et al. Newly designed CRRT membranes for sepsis and SIRS-A pragmatic approach for bedside intensivists summarizing the more recent advances: A systematic structured review. ASAIO J 2013;59:99-106.
7. Mitzner SR, Gloger M, Henschel J, Koball S. Improvement of hemodynamic and inflammatory parameters by combined hemoadsorption and hemodiafiltration in septic shock: A case report. Blood Purif 2013;35:314-5.
8. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004;32:801-5.
9. Rimmelé T, Kaynar AM, McLaughlin JN, Bishop JV, Fedorchak MV, Chuasuwan A, et al. Leukocyte capture and modulation of cell-mediated immunity during human sepsis: An ex vivo study. Crit Care 2013;17:R59.
10. Kumagai T, Takeyama N, Yabuki T, Harada M, Miki Y, Kanou H, et al. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock 2010;34:461-6.
11. Born F, Pichlmaier M, Peterss S, Khaladj N, Hagl C. Systemic inflammatory response syndrome in der herzchirurgie: Neue therapiemöglichkeiten durch den einsatz eines cytokin-adsorbers während EKZ 2014;23:41-6.
12. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to ß-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs 2014;37:422-6.
13. Bracht H, Schneider EM, Weiss M, Hohmann H, Georgieff M, Barth E. Pattern of cytokine removal using an adsorption column CytoSorb during severe candida albicans induced septic shock. Infection 2013;41:1-90.